Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes

    Sanofi and Bristol-Myers Squibb are promoting Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes.

    Plavix is a new platelet inhibitor. It's similar to Ticlid (ticlopidine)...but without the risk of neutropenia.

    Plavix is slightly more effective than aspirin...and causes slightly less GI bleeding.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote